S
The startup has developed a cancer treatment platform that utilizes magnetically propelled nanoparticles to deliver therapeutic agents directly to tumor sites. This targeted drug delivery method enhances tumor penetration and minimizes systemic toxicity, leading to improved patient outcomes and quality of life.
Montréal, Canada
Updated 2 months ago
Funding
$72.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a cancer treatment platform that utilizes magnetically propelled nanoparticles to deliver therapeutic agents directly to tumor sites. This targeted drug delivery method enhances tumor penetration and minimizes systemic toxicity, leading to improved patient outcomes and quality of life.